In the version of this article initially published, 2007 US sales of therapeutic enzymes in Figure 3 were incorrectly listed as $0.7 billion. They should be $0.9 billion. In the same figure, the 2007 growth (%) was incorrectly listed as -14%; it should be 18%. On page 1230, human growth hormone sales growth rate was incorrectly reported as 45%; it should be 5%. The errors have been corrected in the PDF and HTML versions of this article. In the version of this article initially published, in Figure 5 , the $2.40 billion pie section was mislabeled as Rituxan. It should be Procrit. The error has been corrected in the PDF and HTML versions of this article. In the version of this article initially published, on page 1379, column 2, line 7, a parenthesis was misplaced. "…the passenger (often the sense strand)" should have read, "…the passenger (often the sense) strand". The error has been corrected in the HTML and PDF versions of the article. In the version of this article initially published, we neglected to define our categories for public biotech firms. In the following definitions, the dollar amounts refer to a firm's market capitalization or 'cap': microcap, <$250 million; small cap, $250 million to <$1 billion; mid-cap, $1 billion to <$5 billion; large cap, ≥$5 billion. The definitions have been added to Box 2, Figure 1 legend, in the HTML and PDF versions of the article. In the version of this article initially published, in column 3, line 3 in the last paragraph, Debdatta Sengupta was referred to as "he." The text should have read "she" as Sengupta is a woman. The error has been corrected in the HTML and PDF versions of the article.
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